698805004: Ticagrelor (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Platelet aggregation inhibitor\P2Y12 G-protein-coupled platelet receptor antagonist\Ticagrelor (substance)
\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\P2Y12 G-protein-coupled platelet receptor antagonist\Ticagrelor (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Platelet aggregation inhibitor\P2Y12 G-protein-coupled platelet receptor antagonist\Ticagrelor (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Substance with ether structure\Ticagrelor (substance)

\Nucleoside\Nucleoside analogue\Ticagrelor (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2981248017 Ticagrelor (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2981273017 Ticagrelor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

58871000195110 ticagrelor it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

845661000172118 ticagrélor fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

74041000195116 Ticagrelor de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ticagrelor (substance)	Is a	agent antiplaquettaire	false	Inferred relationship	Some
Ticagrelor (substance)	Is a	Nucleoside analogue	true	Inferred relationship	Some
Ticagrelor (substance)	Is a	Platelet aggregation inhibitor	false	Inferred relationship	Some
Ticagrelor (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Platelet aggregation inhibitor (disposition)	false	Inferred relationship	Some
Ticagrelor (substance)	Is a	éther	false	Inferred relationship	Some
Ticagrelor (substance)	Is a	Substance with ether structure	true	Inferred relationship	Some
Ticagrelor (substance)	Is a	P2Y12 G-protein-coupled platelet receptor antagonist	true	Inferred relationship	Some
Ticagrelor (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	P2Y12 G-protein-coupled platelet receptor antagonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ticagrelor 90 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ticagrelor (substance)	Inferred relationship	Some
Product containing ticagrelor (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ticagrelor (substance)	Inferred relationship	Some	1
Ticagrelor 90 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ticagrelor (substance)	Inferred relationship	Some	1
Ticagrelor 90 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ticagrelor (substance)	Inferred relationship	Some	1
Ticagrelor-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ticagrelor (substance)	Inferred relationship	Some	1
Ticagrelor 90 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ticagrelor (substance)	Inferred relationship	Some	1
Ticagrelor only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ticagrelor (substance)	Inferred relationship	Some	1
Product containing only ticagrelor in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ticagrelor (substance)	Inferred relationship	Some	1
Product containing precisely ticagrelor 60 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ticagrelor (substance)	Inferred relationship	Some	1
Product containing precisely ticagrelor 60 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ticagrelor (substance)	Inferred relationship	Some	1
Ticagrelor 90 mg orodispersible tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ticagrelor (substance)	Inferred relationship	Some	1
Ticagrelor 90 mg orodispersible tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ticagrelor (substance)	Inferred relationship	Some	1
Product containing ticagrelor in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ticagrelor (substance)	Inferred relationship	Some	1
Product containing only ticagrelor in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ticagrelor (substance)	Inferred relationship	Some	1

This concept is not in any reference sets